Platforms 02
Molecular Design & Lead Optimization
Keep the isotope locked to its vector until it reaches the tumor.
Stable in the bloodstream, precise at the tumor.
Our physics-informed architecture combines machine learning with radioactive decay kinetics to find the bond between ligand and isotope that holds in circulation and releases at the target. Stability forecasts reach R² = 0.96 across linker and chelator architectures, designed around the short half-life of therapeutic isotopes.